Human hemoglobin A has been crosslinked by diisothiocyanatobenzenesulfonate to give a limited number of products in a yield of =70%. The predominant product was crosslinked between subunits within a tetramer and had a Mr of 64,000; no higher Mr species were formed. This product had one crosslink per tetramer located between the NH2 termini of its a chains, as established by HPLC analysis, amino acid analysis, Edman degradation, and mass spectrometry. This crosslinked derivative had a slightly increased oxygen affinity [Pso = 9 mmHg (1 mmHg = 133 Pa); P50 for unmodified hemoglobin = 11 mmHg], and the retention time of this derivative in the circulation of rats was 2.9 and 3.3 hr at two hemoglobin concentrations (7 g/dl and 14 g/dl, respectively).
Studies on hemoglobin-based blood substitutes have used a variety of chemical modifications. Some reagents used for these chemical modifications are bifunctional crosslinking agents and others yield monosubstituted products. The latter derivatives must be subsequently crosslinked to prevent dissociation of the tetramer into dimers of Mr 32, 000 , which are rapidly filtered by the kidney and thereby removed from the circulation. Examples are the pyridoxal 5'-phosphate adducts with hemoglobin (1) (2) (3) (4) (5) and carboxymethylated hemoglobin (Cm-Hb) (6) (7) (8) (9) , which have low oxygen affinities but require subsequent treatment with a crosslinking agent to prevent subunit dissociation. One of the monofunctional aspirin-based derivatives, however, also has a low oxygen affinity but does not require crosslinking (10) . Several of the bifunctional reagents, such as 2-nor-2-formyl-5-pyridoxal 5'-phosphate (2, 11) , bispyridoxal tetraphosphate (12) , bis(3,5-dibromosalicyl)fumarate (13) , and 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) (14) , yield a crosslinked hemoglobin derivative with a low oxygen affinity when the crosslinker is used with deoxyhemoglobin. In general, the reduced oxygen affinity of a hemoglobin derivative together with its inability to dissociate form the basis for its consideration as a blood substitute. However, the relationship between oxygen affinity and plasma retention had not been carefully analyzed to date.
Some crosslinked hemoglobin derivatives have a Mr of 64,000-i.e., crosslinking only within a given tetramer (12) (13) (14) (15) , and others have Mr values of 128,000 or greater-i.e., crosslinking between hemoglobin tetramers (16, 17) . The latter derivatives include the dextran-hemoglobin complexes (18) , hemoglobin conjugates with polyethylene glycol (19) , and glutaraldehyde-treated pyridoxylated hemoglobin, which are very large polymers of different molecular weights. The optimal molecular weight for a blood substitute has not yet been defined. Even though some investigators feel that the minimum molecular weight for a hemoglobin-based blood surrogate is 128,000 (20) , good evidence suggests that a Mr of 64,000 is probably sufficient to sustain effective concentration of a blood substitute in the circulation. For example, serum albumin, which has a Mr of --60,000, is not cleared from the circulation. Furthermore, studies on the clearance time of crosslinked tetrameric hemoglobin derivatives also support this view (21) (22) (23) .
In this communication we examine 2,5-diisothiocyanatobenzenesulfonate (DIBS) as a crosslinking agent with several objectives. (i) A bifunctional crosslinking reagent that generates a defined tetrameric crosslinked species was desirable.
(ii) The plasma-retention time of a well-characterized crosslinked tetramer had to be measured to compare its clearance rate with that of the uncrosslinked Cm-Hb derivative and to ascertain the influence of the oxygen affinity of each derivative on its plasma-retention time.
METHODS AND MATERIALS
Whole blood from normal individuals was washed, lysed, and dialyzed as described (6) (7) (8) (9) . For studies with deoxyhemoglobin, the solution of oxyhemoglobin (=200 jAM) was bubbled with humidified N2 for =45 min. Spectra were recorded on a Cary 2200 spectrophotometer. Inositol hexaphosphate (InsP6) and glycylglycine were purchased from Sigma. DIBS Solutions were administered through the carotid catheter, and blood samples were taken at intervals. The plasma hemoglobin concentration was measured as the absorbance at 524 nm (26) . Plasma-clearance rates were calculated from fits to exponential functions obtained by nonlinear leastsquares methods. Rates were compared by using 95% confidence intervals about the rate as a measure of significant difference. Cm-Hb, a modified but uncrosslinked hemoglobin with a low oxygen affinity prepared as described (6-9), was used as a clearance standard because this material is excreted as fast as unmodified hemoglobin.
Analytical Procedures. The elemental analyses of DIBS were done by Robert Buzolich (The Rockefeller University Microanalytical Services). UV spectra were obtained with a Cary 2200 instrument. HPLC separation ofthe globin chains, crosslinked or uncrosslinked, was performed with a Beckman-Altrex system on a C18 Vydac ODS column with a gradient from 45-65% of 0.1% trifluoroacetic acid/80%o (vol/ vol) acetonitrile with the balance 0.1% trifluoroacetic acid. Amino acids were analyzed either with a Beckman 6300 analyzer with an IBM-AT System Gold enhancement or on the original Moore and Stein amino acid analyzer (30 (Fig. 2) . The protein in peak 1 is of Mr 16,000, whereas the protein in peak 2 is Mr 32,000 (Fig.  2 Inset). As shown in Table 1 , amino acid analysis of the protein in peak 1 indicated that it was the chain of hemoglobin; the protein comprising peak 2 had the amino acid composition of the a chain of hemoglobin.
Identity of the a-a crosslinked globin chains was confirmed by MS. The matrix-assisted laser desorption mass spectrum of the material labeled as peak 2 (Fig. 2) (Fig. 3) . The For purposes of sequencing by Edman degradation, the DIBS-crosslinked a chains were first hydrolyzed from the a-a globin chains by treatment for 16 hr with 5% (vol/vol) acetic acid at 56°C. Subsequent SDS/gel electrophoresis indicated that most of the crosslink (80%6) had been cleaved.
When this sample was subjected to HPLC, under the conditions described in Fig. 2 , one major peak eluted just before the remaining uncleaved a-a crosslinked globin (peak 2) (data not shown). This material gave a discrete sequence in high yield beginning at the second amino acid residue of the a chain: Leu2-Ser3-Pro4-Ala5-Asp6-Lys7-Thr8-Asn9-Val10 (a chain minus NH2 terminus). Therefore, the original NH2-terminal valine residue was removed during the cleavage in acetic acid together with the DIBS crosslink, presumably by a cyclization similar to the Edman reaction. In addition to the residual a-a chains (21%), two uncrosslinked chains were isolated in a pure state (45% yield). Each of these purified chains (50% yield) gave the same single sequence shown above; sequencing was done on 400 pmol of chain with an Amino acids shown in boldface (a chain) or in italics ( chain) are those for which significant differences exist between a and d chains. Values for cysteine, methionine, tyrosine, and tryptophan are not included because these amino acids are either partially or completely destroyed during acid hydrolysis; the special conditions for hydrolysis or analysis to protect these amino acids were not needed for identification ofthe chain. Because recovery ofthe listed amino acids is nearly complete, the DIBS crosslink is probably completely hydrolyzed upon acid hydrolysis in 6 M HCO with regeneration of the amino acid side chain to which the DIBS was attached. and full cooperativity (n = 2.5). As described (6) (7) (8) (9) , Cm-Hb has a significantly lowered oxygen affinity of 28 mmHg. For the plasma-retention studies, 2.5 g of component B (Fig. 1 ) was isolated by a scale-up of the procedure described above. This material behaved as one component upon rechromatography on DE-52. The isoelectric focusing pattern ofcomponent B was similar to that ofpurified hemoglobin AO. Each sample was dialyzed against sterile isotonic saline and then sterilized by filtration through a 0.2-;Lm filter into a sterile tube. The endotoxin content, as measured by the Limulus test, was 0.2 ng/mg of hemoglobin. The same amount of Cm-Hb (2.5 g) was isolated as described (6, 9) . Each hemoglobin derivative was injected into the circulation ofrats as described above. The plasma concentration half-life of Cm-Hb was 35 and 41 min (0.6 and 0.7 hr) at the two concentrations tested (Fig. 4) . The DIBS-crosslinked hemoglobin had a plasma concentration half-life of 2.9 and 3.3 hr.
After equilibrium, pseudo-first-order kinetics for the clearance were seen. Differences in plasma-concentration halflives between the modified hemoglobin species were highly significant. The small increase in plasma concentration halflife seen in each species with increased dose was not significant at the doses studied. DISCUSSION Kavanaugh et al. (14) described the crosslinking of hemoglobin A with a compound similar to the one used in the present study. However, they showed that DIDS crosslinked the NH2-terminal residues of the f chains, unlike the smaller reagent used in this study that crosslinks the major component B between the NH2-terminal residues of the a chains. Component B of DIBS-crosslinked hemoglobin resembles the hemoglobin derivative described by MacLeod and Hill (29) , which is also crosslinked between the two a chains. However, there is no cooperativity for this latter derivative (n = 1.0), whereas the DIBS-crosslinked hemoglobin has ful cooperativity (n = 2.5). The difference in oxygen affinity between DIDS-and DIBS-crosslinked hemoglobins is reminiscent ofthe effects of sodium cyanate on the oxygen affinity of hemoglobin (24) . Thus, carbamoyl or DIBS groups on the a chains lead to increased oxygen affinity, whereas carbamoyl or DIDS groups on the (3 chains lead to decreased oxygen affinity.
Whereas the plasma-concentration half-life ofextracellular hemoglobin is a function of both administered dose and animal species used in testing, the values reported here were estimated in rats with solutions in which volume and concentration are comparable with previous reports (34) . The DIBS-crosslinked hemoglobin has a prolonged retention in plasma, comparable to that of other crosslinked hemoglobins that are under consideration as blood substitutes. DIBScrosslinked hemoglobin would be expected to have a longer half-life when administered in greater dose and to larger animals. The results of this study clearly show that uncrosslinked carboxymethylated hemoglobin, which has a low oxygen affinity, has about the same retention time as unmodified hemoglobin AO (35) . Hemoglobin component B crosslinked by DIBS does not have a lowered oxygen affinity, but its retention time was the same as that of hemoglobin crosslinked with an aspirin derivative; the latter has a Mr of 64,000 and lowered oxygen affinity (36) . Therefore, the retention time of a hemoglobin derivative appears to be a function of its ability to dissociate into dimers and not a function of its oxygen affinity.
